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ABSTRACT The control of purine biosynthesis in a yeast mutant deficient for
uracil, adenine, and histidine has been studied in vivo. The adenine mutation
causes accumulation of aminoimidazole ribotide in the cells. The control curve
relating steady-state purine nucleotide level in the cell to rate of synthesis in the
de novo purine synthetic pathway has been determined. Control in the cell de-
pends on a feedback mechanism involving end-product inhibition. The transient
responses of the purine nucleotide pool to changes in adenine input have been
studied. Under certain conditions the pool overshoots when shifting from one
steady-state to another. Transient changes in nucleotide levels are followed by
inverse changes in the rate of attempted de novo purine synthesis. A study of the
transient responses of specific intracellular nucleotides suggests that inosinic acid
controls the rate of attempted purine synthesis. The transient response of nucleic
acid synthesis rate to changes in nucleotide levels was studied and the implica-
tions for regulation of nucleic acid synthesis discussed.
INTRODUCTION
The purpose of the general investigation of which this paper represents the first part
is to utilize the technical advantages of a yeast mutant with multiple independent
biochemical deficiencies in the investigation of the internal regulation of systhesis in
each of several pathways and the coordination or mutual regulation among path-
ways. The investigation is designed to yield data for the formulation of a mathemati-
cal model of the functional characteristics of the system of several pathways. The
system as a whole can be studied effectively only in vivo and this is what is done.
Interpretation of the in vivo studies is facilitated by the accumulation of knowledge
of biochemical pathways and mechanisms of regulation by others studying enzymes
in vitro.
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This paper presents a study of regulation of purine and purine neucleotide syn-
thesis and the relations of these to nucleic acid synthesis in a Saccharomyces
cerevisae haploid strain with genetic blocks in the purine, pyrimidine, and histidine
pathways. The adenineless mutant used in these investigations provided two special
advantages. First, that part of the purine biosynthetic pathway preceding the block
is intact and the pathway rate of synthesis can be estimated from the initial rate of
accumulation of the terminal product of the intact path-AIR.' Secondly, manipula-
tion and specific labeling of the purine nucleotides do not depend on maintaining a
level of these high enough to cut off or spare internal synthesis of purines, so that
low steady-state nucleotide levels can be maintained, measured, and correlated with
the rate of attempted de novo purine synthesis.
The studies of many workers have shown that biosynthetic pathways in the cell
are generally regulated by a form of rapid control (end-product inhibition) and a
slower control which involves removal or manufacture of the synthesizng machinery
of the cell (enzyme induction and repression). It is to the rapid form of control that
attention is directed in this study.
Several investigations especially relevant to the present study have appeared in the
literature. Identification of AIR as an intermediate accumulating in another adenine-
less yeast has been made by Friedman and Moat (4) and in bacteria by Love and
Levenberg (11). Gots (5) and Gots and Goldstein (6) have studied certain aspects
of purine regulation in bacteria. Incorporation of adenine into wild type Sac-
charomyces has been studied by Halvorson (7) and Harris and Neal (8) and in
Torulopsis by Cowie and Bolton (3). The genetics of adenineless strains of yeast
has been described by Roman (14). The reaction chains and cycles used as a basis
for interpretation in the paper have been described by Buchanan (2) and
Magasanik and Karibian (12), among others.
METHODS AND MATERIALS
The yeast strain employed in these studies is S1237A, developed and given to us by Dr.
R. K. Mortimer. It is a haploid Saccharomyces cerevisiae containing three separately
induced and independent biochemical deficiency mutations combined into the one strain.
The genotype is ur1 ad, his8; the colonies become red in the absence of adenine. The uracil
requirement is satisfied by uracil or uridine but not by uridylate, UDP, cytidine, cytidylate,
thymine, thymidine, or orotate. The adenine requirement is satisfied by adenine or
hypoxanthine but not by adenosine, adenylate, ADP, guanine, guanosine, deoxy deriva-
tives of the above, aminoimidazole carboxamide, or AICA-riboside. Of these only the
auxotrophic compounds, adenine and hypoxanthine, prevent formation of the red pig-
ment. The histidine requirement is satisfied by none of the compounds above.
Except for the preliminary work reported in the first section, cells were harvested in
IAbbreviations used throughout text: AIR, 5-aminoimidazole ribotide; PRPP, 5-phosphoribosyl-
l-pyrophosphate; SP, TCA-soluble pool; IP, TCA-insoluble pool; SP* or IP* represents the C14-
labeled pool; IMP, inosinic acid.
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log phase (107 cells/ml) after hundredfold growth in synthetic medium2 capable of sup-
porting growth to 2 x 108 cells/ml. Only at concentrations above 108 cells/ml were pro-
tein and RNA synthetic rates per cell decreased. These rates were constant in the range
107 to 108 cells/ml, indicating that cells in this range were not adapting to stationary
phase. In experiments on regulation where growth was permitted the cell concentration
never exceeded 2 x 107 cells/ml. Cells were harvested by centrifugation or membrane
filter and immediately resuspended in preheated and preaerated synthetic medium. No
difference in effect of fresh or used synthetic medium was found with respect to purine
and pyrimidine synthesis, so fresh medium was used ordinarily. Incubation was always
at 300C with aeration
Aliquots for assay of radioactivity were taken as described later; the larger quantitites
of cells required for AIR assay were obtained by filtration through a 50 mm membrane
filter, a process requiring about 2 minutes. Cells were then immediately extracted in 5
per cent TCA at room temperature, and the extract assayed for AIR with the Bratton-
Marshall test (16) immediately. TCA extraction gives reproducible recovery of AIR,
and better or equal yield than ethanol, toluene, heating in water at 85-100° for 3 to 30
minutes, or sonic disruption.
The genetic block responsible for the adenine requirement of S1237A is in the step
succeeding AIR production in the purine biosynthetic pathway. This was deduced from
the facts that AIR accumulates immediately in the cells in the absence of adenine and
that the steps succeeding AIR are effectively irreversible. AIR does not appear in the
growth medium until several hours after the start of accumulation in the cells. It is rela-
tively stable inside the cell. That AIR is stored in the cells is consistent with the known
presence of large pools of free amino acids in yeast.
The spectrum of the chromophore resulting from application of the Bratton-Marshall
test to AIR is sufficiently unique to identify the compound accumulating in S1237A as an
aminoimidazole. Further identification was obtained using the methods Friedman and
Moat (4) employed to identify aminoimidazole riboside in the media of purine- and
biotin-deficient yeasts and the methods of Love and Gots (5) and Levenberg and
Buchanan (9). This involved fractionation of the yeast extract on Dowex 50 or Dowex 1,
followed by paper chromatography of the fractions in butanol-acetic acid-water. Ex-
tracts of cells grown with and without adenine were run for comparison. Detection and
identification on the chromatogram were made by means of the Ames and Mitchell spray
for imidazoles (17), determination of R,, elution of spots for Bratton-Marshall testing,
and pentose determination. Only one pentose imidazole appeared in the extracts of cells
incubated without adenine that did not appear in cells incubated with adenine. This
compound had the characteristics of AIR on the basis of the above tests. The behavior of
the compound on the ion exchange resins indicates that it is largely the ribotide rather
than the riboside which is extracted from the cells. Comparison with authentic AIR was
made possible by a gift of the latter from Dr. J. Buchanan.
It was desired to label cells and then determine the radioactivity of whole cells, acid-
soluble and acid-insoluble fractions. It was found that collection of whole or TCA-
extracted cells on 0.45 micron membrane filters was not only expeditious but allowed
2Synthetic medium composition: Vitamins, dextrose, trace elements, and salts as in Difco
bacto yeast morphology agar with these exceptions: Inositol 2 /tAg/liter, K2HPO& 5.3 gm/liter,
KH,PO, 2.6 gm/liter. Substitutions: Ammonium sulfate 5 gm/liter, L-tryptophan 0.2 gm/liter,
1-glutamate 0.2 gm/liter, 1-methionine 0.2 gm/liter, 1-tyrosine 0.25 gm/liter, cysteine 0.2
gm/liter. Additions: Adenine and uracil 50 ,ug/ml, histidine 200 ,ug/ml.
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recovery of virtually all radioactivity (1). Collection and washing on the filter of whole
cells required less than a minute. If no more than 5 x 1O7 cells are collected per 25 mm
filter, the layer that results is "infinitely thin" with respect to C' beta emission. The per
cent standard deviation of a series of membrane filter samples was close to 1 per cent.
The labeled compound used was adenine-8-C"', from Calbiochem Co., Los Angeles.
Radioactive compounds of about 0.1 ,uc/,ug were mixed with sufficient carrier to give
7.5 X 10' ,uc/,ug for tracer experiments.
In studies of the uptake of adenine C' the compounds receiving the label were sepa-
rated into the usual two fractions-the acid-soluble pool (SP) and acid-insoluble pool
(IP). The acid-soluble compounds were extracted in cold 5 per cent TCA for 1 hour,
followed by TCA wash. Alternatively, this pool was extracted in 95 per cent ethanol for
3 minutes at 50C, followed by extraction in 50 per cent ethanol, 3 minutes at 50°C.
The two methods give identical results. The insoluble residues of extraction were collected
on membrane filters. The activity of the soluble fraction was calculated by subtracting
the activity of the insoluble fraction from whole cell activity or by direct assay.
For direct assay an aliquot of the extract is evaporated on acid-washed stainless steel
planchets. By careful adjustment of temperature it is possible to drive off TCA as well
as water, leaving the soluble compounds deposited in a thin layer for direct counting.
Separation and quantitative measurement of the individual C14-labeled soluble com-
pounds were accomplished with high voltage electrophoresis. The ethanol extract is
evaporated quickly under vacuum, water-insoluble lipids removed, and the residue ap-
plied to 50 cm strips of Gelman sepraphore membrane paper. By the use of filter paper
wicks, about 45 cm of the membrane are available for electrophoretic separation. Citrate
buffer, pH 2.7, is used for the electrophoresis which is carried out in a tank containing
Varsol as coolant. A field of 50 v/cm was applied for 1I to 2 hours. The purine
nucleotides IMP, AMP, ADP, ATP, GMP, GDP, and GTP are clearly resolved by this
method. The per cent recovery of radioactive standards of AMP, ADP, GDP, and ATP
run through the entire process of extraction and electrophoresis ranged from 85 to 95
per cent. In the experiments to be described here the cells in log phase were exposed to
adenine C1' before the start of experiment long enough for the soluble-labeled components
to reach steady-state activity, at which time the activity of each component is a measure
of its amount. The activities of the nucleotides separated by electrophoresis were meas-
ured with a Vanguard scanner and integrator.
RESULTS
AIR Production as a Function of External Adenine and Uracil Concentra-
tions. Since yeast S1237 cannot produce its own purine end-product nucleotides
the level of these can be manipulated in response to the external level of adenine.
Although internal nucleotide levels are not necessarily proportional to external
adenine concentration, the effect of manipulation of the latter on feedback inhibi-
tion of the blocked purine pathway was studied preliminary to study of the former.
For this study stationary phase cells adapted to the synthetic medium in the pres-
ence of adenine, uracil, and histidine were transfered to medium containing no
uracil, zero or 20 ug/ml histidine, and various concentrations of adenine. The
amount of AIR per cell was determined as a function of time. The presence or
absence of histidine had no significant effect on AIR production. Fig. 1 shows ac-
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FIGuRE 1 Intracellular accumulation of AIR versus time in a stationary phase popu-
lation. AIR per cell is plotted here in arbitrary units. Cells grown in 20 /Ag/ml
adenine were transferred at time zero to the following concentrations of adenine in
synthetic medium: A, 0 /.&g/ml; B, 1.5 jLg/ml; C, 3.0 jg/ml; D, 5.0 pglml.
cumulation of AIR in the presence of histidine and 0, 1.5, 3, and 5 ,Ag/ml adenine.
The rate of AIR accumulation is nearly constant during the first 40 minutes at
all adenine concentrations, indicating that during this initial period the accumulated
AIR does not inhibit its own production nor is it transformed or degraded, be-
cause either of these processes would tend to make the curve level off. As little
as 1.5 pug/ml adenine inhibits AIR production appreciably and 5 jug/ml reduces
the rate to about 20 per cent of its value in the absence of adenine.
The inhibition is not due to a general toxic effect of adenine because the over-all
growth rate of the cells is maximal at levels of adenine above about 2 1.Zg/ml and
is not lowered even at adenine levels of 100 jug/ml. AIR production can be switched
on or off with less than a 10 minute lag in response to changes in external adenine
level from 5 jug/ml to zero and back to 5 jug/ml.
A similar type of experiment was performed to determine the effect of various
levels of uracil on feedback inhibition of the purine pathway in combination with
various levels of adenine. All combinations of 0, 2, 5, and 20 pg/ml uracil with
0, 2, 4, and 7.5 pg/ml adenine were tried and AIR assays made at 30 minutes'
incubation and later. In all cases uracil had no significant effect, the accumulation
of AIR was affected only by the level of adenine.
The data described in this section provided a basis for more detailed investiga-
tion of regulation of purine synthesis. In particular, the following hypotheses are
supported: (a) Adenine and/or its derivatives inhibit purine synthesis at a step
preceding the synthesis of AIR. (b) The degree of inhibition can be varied over
a wide range in this system. (c) The rapid, reversible response indicates that in-
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hibition, as distinguished from repression and induction of enzymes, is the pri-
mary mechanism involved in controlling purine synthesis in these short term ex-
periments. (d) The initial rate of accumulation of AIR after synthesis is turned on
provides a valid index of the rate of synthesis of that part of the purine pathway
preceding the genetic block.
Characteristics of the Purine End-Product Pool and Its Relation to Feed-
back Inhibition of AIR Production in Log Phase Cells. Figs. 2 and 3 present up-
take curves for adenine C14 at various concentrations in complete medium, with
20 pg/ml uracil and histidine. For these experiments log phase cells were first
incubated for 2 hours in full medium lacking adenine to reduce the size of the
TCA-soluble pool (SP). This reduced the time required for the purine components
of the SP to exchange with adenine C14. The SP* curve for cells not first depleted
of adenine (not shown here) was similar but an additional 20 to 30 minutes was
required before the SP* curve leveled off. To prevent significant change of con-
centration of adenine in the medium during uptake at the lower adenine concen-
trations it was found necessary to reduce cell concentration to 6 x 105 cells/ml.
In each of the experiments described in this section adenine concentration was
essentially constant during the experiment.
Fig. 2 shows the incorporation of radioactivity into the SP* and into the cells
as a whole (total) as functions of time when adenine C14 at levels of 2, 3, or 4
jug/ml is added at time zero. The activities plotted have been corrected for growth
of the population during the experiment. It is seen that the SP* approaches a
steady-state or dynamic equilibrium level after 15 minutes which is independent
of external adenine concentration. 1 or 20 jug/ml adenine C14 give curves similar to
those of Fig. 2. There is apparently a storage pool which exchanges slowly with
the direct precursors of nucleic acid (more evidence for this will be pointed out
later) and this accounts for the slow increase of SP* after 15 minutes. Note that
the SP* fills faster in the first 15 minutes the higher the adenine C14 concentration
but reaches the same steady-state level in each case. The total rate of incorporation
reaches and maintains approximate constancy after 15 minutes, and is not de-
pendent on adenine concentration so long as the SP* is not; i.e., in the range 1 to
20 ,g/ml. The TCA-insoluble labeled pool IP*, which consists of labeled nucleic
acids, is the difference between total and SP*. In Fig. 2 the IP* after 15 minutes
is a straight line nearly parallel to the curve of total incorporation. (See also Fig.
3.) The rate of transfer of adenine through the precursor pool has reached steady-
state and is independent of external adenine concentration in the range 1 to 20
jug/ml. Further evidence that the rapidly labeled part of the SP* consists of direct
precursors of IP* will be presented later.
Fig. 3 shows the uptake curves for 1 and 0.2 ,g/ml adenine C14. Not shown
are curves for uptake in the range between 1 and 0.2-these fall between the curves
shown. At 0.2 pg/ml adenine the cells are unable to take up adenine fast enough
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FiouRE 2 Incorporation of adenine-C" into the acid-soluble pool (SP*) and total
cellular uptake (total). The symbols are: U, 4 ,ug/ml adenine C1'; A, 3 ,ug/ml; 0, 2
jAg/ml. For simplicity the first points on the total curve for 2 and 3 jug/ml are omitted;
these fail below the corresponding points for 4 ,ug/ml adenine CA.
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FIGURE 3 Incorporation of adenine CIA into the acid-soluble pool (SP*) and acid-
insoluble pool (IP*). The symbols are: A, 1 jug/ml adenine C"; 0, 0.2 /Ag/ml
adenine C". These concentrations remain essentially constant during the course of the
experiment.
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to reach the normal steady-state level. Instead a level about one-third the 1 ,ug/ml
adenine level is attained in the same time, and the SP* then comes into dynamic
equilibrium with the rate of entry of adenine into cells equal to the rate of incorpora-
tion into the IP*. The rate of nucleic acid synthesis as measured by IP* rate now
depends on external adenine concentration. In fact, the rate of incorporation of
adenine C14 into IP* has decreased to one-third of the rate in 1 ,ug/ml adenine in
direct proportion to the SP* level. This and the achievement of steady-state at the
same time in both cases indicate that the transfer rate of an adenine C14 molecule
along the precursor chain is the same in both cases but the number of molecules
entering the cell per unit time is decreased to one-third in 0.2 pg/ml adenine.
If feedback control of purine synthesis involves one or more of the adenine C'4-
labeled compounds of the SP*, we expect lowering of the SP* to decrease feed-
back inhibition. An experiment was made with cells treated as described for Fig. 3
but with AIR per cell determined as a function of time. The rates of AIR synthesis
in the interval 40 to 60 minutes corresponding to steady-state SPs for 1 and 0.2
,g/ml adenine were determined. The rates in arbitrary units were 84 for 0.2
adenine and 20 for 1 adenine, or a ratio of 4.2 to 1. Comparing with the correspond-
ing SP* ratio of 1 to 3 it is apparent that there is an inverse correlation between SP*
level and AIR rate.
Rates of AIR synthesis versus precursor pool level measured when the SP* has
reached steady-state between 60 and 70 minutes are plotted in Fig. 4. The precursor
pool level is determined by subtracting the activity of the storage pool (curve A
SP* at 60 minutes (Fig. 5)) from the over-all SP* activity. The shape of the curve
is in doubt because of scatter of the points taken from various experiments but it
is consistent with a mechanism of regulation involving allosteric competitive inhi-
120 _
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FIGuRE 4 Rate of synthesis of AIR versus steady-state purine nucleotide precursor
pool level. See text for details.
BIOPHYSICAL JOURNAL VOLUME 4 1964158
I
...
.: T.ES.
FIGURE 5 Shift down experiment. The cells were incubated in 5 ,ug/ml adenine C'
until steady-state SP* was attained and transferred at time zero to the following
adenine concentrations: A, 0; B, 0.15 ,ug/ml; C, 0.25 jug/ml; D, 0.35 pg/mi; E, 5.0
pg/mi. SP*, acid-soluble pool; IP*, acid-insoluble pool.
bition (13) by inhibitor(s) whose concentrations are proportional to the precursor
pool level.
Transient Changes in the Purine End-Product Pool and in the Levels of
Specific Nucleotides Related to the Control of de Novo Purine Synthesis. The first
series of experiments was designed to reveal the kinetics of shift from high level
steady-state SP* to low level steady-state and the relation between AIR rate and
SP* in transition and in new steady-state. Although levels of adenine as low as
0.15 Ag/lml were used to maintain low SP* levels, the concentration of adenine in
the medium was not appreciably reduced during an experiment.
The SP was labeled beforehand by incubating cells in 5 Ag/ml adenine CH4 for
several hours to obtain steady-state SP*, then the cells were removed quickly by
filtration and immediately resuspended in medium of the same composition (in-
cluding 20 jg/ml uracil and histidine) except for adenine. Fig. 5 shows a typical
experiment where the shifts were to 0, 0.15, 0.25, 0.35, and 5 jug/ml adenine C'4.
These concentrations were chosen under 1 ,ug/ml so that the SP* level would be
forced to shift down. Shifting down to 1 zg/ml does not shift the SP* level down.
The process of changing media does not shift the SP* down, as can be seen from
the 5 ,ug/ml control curve.
Curve A shows the course of IP* and SP* on transfer to zero adenine. The ac-
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tivity of the SP* declines to about half the initial value by 30 minutes and then de-
clines very slowly. The rapidly decaying component has a time constant of about
10 minutes (decay to I/e). The time constant (increase by e) for uptake of
adenine C14 at 5 ,ug/ml into cells starved of adenine (determined from data like
those of Fig. 2) is also about 10 minutes. The activity lost from the SP* is trans-
ferred directly to the IP* as can be seen from the upper A curve and none leaks
out of the cell. This is good evidence that that part of the SP* with a time constant
for filling or emptying of 10 minutes is the pool of direct precursors of the IP*.
It will be referred to henceforth as the precursor pool and the slowly turning over
component of the SP as the storage pool. If the latter is really a storage pool which
fills or empties slowly, then its activity should not be swept into the IP* by a chase
of unlabeled adenine. An attempt to answer this was made by administering 5
,Ftg/ml unlabeled adenine at 50 minutes and following the level of labeled material
in SP* and IP* for an additional 30 minutes. No increased rate of change in IP*
or SP* was observed. In 30 minutes about half of the new adenine taken up will
appear in the IP* (see Fig. 2). If the remaining labeled components were all in-
termediates in the sequence adenine to nucleic acids and not in storage, at least
half of them should have appeared in the IP*. Since this did not occur the remang
labeled component(s) are evidently not direct precursors of nucleic acid.
Curve B SP* shows a "critical damping" approach to a new steady-state in
0.15 pg/ml adenine. Although the new level is not much higher than the level in
0 adenine, the rate of transfer through it to the nucleic acids of labeled adenine is
fairly high as indicated by the slope of the IP* curve.
SP* curves C (0.25 ug/ml adenine) and D (0.35 jg/ml adenine) are in-
teresting cases of overshoot oscillation in approaching new steady-states. Con-
siderable effort has been made to develop a kinetic model of the phenomenon. The
most interesting conclusion obtained from this effort is that a rate constant of one
or more of the reactions involved must change after a lag. Such a rate constant
change would most likely be due to change in level of enzyme. Some insight into
the reason for the overshoot can be gained by reference to the IP* curves for B,
C, and D. These all follow the same course before 20 minutes, a period during
which the precursor pool is reduced because nucleic acid synthetic rate is not re-
duced fast enough to equalize output to input while the pool level is still high. After
20 minutes the IP* rate is reduced for B, C, and D and to about the same level.
The reduced rate of nucleic acid synthesis is high enough to keep B SP* low (and
hence to increase the rate of attempted purine synthesis, as will be seen next) but
lower than the input rate of adenine to the precursor pool for C and D. Hence
the precursor pools of C and D begin to fill again. The disparity between input and
output persists, allowing the pools to continue filling for a time.
In the next series of experiments the synthesis of AIR during the course of
the nucleotide pool variations after shift of adenine level was investigated. From
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AIR analyses made at 10 minute intervals the rates of AIR synthesis in each interval
were calculated and these are plotted in Fig. 6. Curve 1 corresponds to a shift
down to zero adenine, curve 2 to a shift to 0.3 jug/ml adenine, and curve 3 to no
shift. Within 10 minutes after the shift to zero or 0.3 adenine the rate of AIR syn-
thesis increases more than 20-fold. This is apparently the maximum rate the de novo
pathway is capable of since it increases no further during 2 hours' incubation of
the cells in zero adenine. Curve 3 shows that the rate of AIR synthesis remains
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FIGuRE 6 Rate of AIR synthesis after shift from 5 pg/ml adenine to lower levels.
Curve 1, zero adenine; curve 2, 0.3 ,ug/ml adenine; curve 3, no shift.
low as long as the purine nucleotide pool level is maintained by external adenine
at 1 iAg/ml or more. Curve 2 shows that AIR synthesis is switched on immediately
to maximum rate after the shift to 0.3 ug/ml adenine, but declines rapidly between
30 and 40 minutes after the shift to a new constant rate which is about 25 per cent
of the maximum rate. (It is worth emphasizing again that the adenine in the
medium is not exhausted or reduced during the experiment.) By comparison with
curves C and D of Fig. 5 it is seen that the AIR rate goes up when the SP* nucleo-
tide pool level goes down and when the pool level goes up after 30 minutes the
AIR rate drops rapidly.
The observation that AIR synthesis is inhibited after shift to 0.3 jug/ml adenine
only when the purine nucleotide pool, having reached a minimum earlier, begins
to increase, provides an approach to the problem of which nucleotide(s) are
effective in vivo in inhibiting de novo purine synthesis. If the hypothesis that AIR
synthesis is shut off by end-product inhibition is accepted, then one or more of
those end-products which increase just before shut-off must cause the shut-off.
Three experiments were performed in which quantitative analyses of the levels
of AMP, ADP, ATP, GMP, GDP, and IMP were made. These and a constant
component tentatively identified as a coenzyme account for more than 80 per cent
of the activity derived from adenine C14 and soluble in ethanol-water. Most of the
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remaining ethanol-water-soluble C14 is found in adenine or adenosine and a small
amount in GTP.
In Fig. 7 a radioactivity proffle of the steady-state labeled punne nucleotides ex-
tracted from cells growing in 5 jug/ml adenine C14 and separated by strip electro-
phoresis is presented. The areas of the peaks correspond to the amounts of each
component. The excellent resolution of components demonstrated in this figure and
automatic digital integration of activities during scanning of the strip contributed
a great deal to the accuracy and reproducibility of the nucleotide analysis.
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FRouRE 7 Radioactivity profile of the ethanol-water soluble compounds separated
by strip electrophoresis from cells labeled in 5 jig/ml adenine C14. The peaks are: 1,
AMP; 2, GMP; 3, ADP; 4, IMP; 5, GDP; and 6, ATP. The peak between 2 and 3
is a constant component used for standardization.
Shift experiments were performed as described for Fig. 5, the shift down being
to 0.3 jug/ml adenine C14. Analyses of the average amount of each nucleotide per
cell were made of samples taken at varying times up to 70 minutes after the shift.
Since recovery of nucleotides in duplicate samples varied by as much as 15 per cent
use was made of the fact that the coenzyme component previously referred to
maintained constant level after a shift, and this component was employed as an
internal standard. By normalizing to this standard duplicate analyses agreed to
within 5 per cent. Results are presented in Figs. 8 and 9.
It is seen that AMP, which is as abundant as all the other nucleotides taken
together, declines quickly after the shift to a new steady-state level about two-thirds
of the pre-shift level. Since AMP is the major component and is known to be an
effective nucleotide inhibitor in vitro of PRPP amidotransferase (15), we might
expect it to be dominant in end-product inhibition. Nevertheless, the inhibition is
released when AMP is still at high level and there is no increase in AMP at the
time inhibition is reestablished. ADP remains relatively constant after the shift
with the possible exception of the first 10 minutes. Preliminary experiments with-
out internal standard which suggested that ADP increased at 30 to 40 minutes
have not been borne out by more rigorous investigation. ADP is therefore not
involved in the cycling of inhibition.
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FiGuaE 8 Nucleotide levels after shift down. The cells are labeled to steady-state
in 5 ,ug/ml adenine C14 and then shifted at time zero to 0.3 Atg/ml adenine C14.
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FiGuRE 9 Nucleotide levels after shift down. The cells are labeled to steady-state in
5 ,ug/ml adenine C14 and then shifted at time zero to 0.3 ,ug/ml adenine C"A.
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ATP level doubles after the shift and then declines gradually starting at about
30 minutes. Thus it is out of phase with the course of inhibition and ATP is there-
fore not the inhibitor. GMP level drops immediately after the shift to about 20
per cent of its original level and it then stays at this level. It does not rise at the
time AIR rate is reduced.
Of the nucleotides tested, IMP is the only one that drops immediately after the
shift as AIR rate rises and increases at the time AIR rate decreases. Although it
does not regain its original level it comes up to about 75 per cent of it; this may
be why the rate of AIR synthesis does not drop all the way to minimum value by
40 minutes-the IMP level may not be high enough to give maximum inhibition.
IMP then behaves as expected of a controlling end-product inhibitor.
DISCUSSION
Wyngaarden and Ashton (15) have shown that ATP, ADP, AMP, GDP, GMP,
and IMP competitively inhibit in vitro the binding of PRPP to the first enzyme
unique to the purine pathway, phosphoribosyl-pyrophosphate amidotransferase.
According to these data IMP inhibits PRPP amidotransferase effectively, but not
as effectively as AMP, ADP, and ATP. Since in our yeast the latter are found in
greater amount than IMP (IMP accounts for about 12 per cent of the purine nucleo-
tide pool), one must assume that IMP is either a better inhibitor in vivo than
Wyngaarden and Ashton's data suggest or that compartmentation of IMP and
the enzyme provides a high local concentration of IMP in the vicinity of the en-
zyme. Another possibility is that IMP acts on another enzyme of the purine path,
but this is unlikely because such control subsequent to the first irreversible step
of the purine path is uneconomical.
Although the in vitro experiments of Wyngaarden and Ashton demonstrate that
PRPP amidotransferase is sensitive enough to purine nucleotides to be inhibited
at the concentrations of these probably found in the cell, it is possible that other
mechanisms of control of purine synthesis by adenine or its derivatives exist. Gots
(5) has suggested that the conversion of adenine to AMP might lower the level
of PRPP enough to cut off de novo purine synthesis. In the present system, at-
tempted de novo purine synthesis continues to be inhibited after the rate of uptake
of adenine becomes equal to its rate of incorporation into nucleic acids. The rate
of use of PRPP at a given rate of nucleic acid synthesis should be the same per
AMP molecule formed, whether the ribose phosphate is attached directly to adenine
or through the steps of de novo purine synthesis. Hence the same level of PRPP
should be found in adenineless mutants in steady-state uptake of adenine as in
wild type yeast synthesizing nucleotides de novo. Hence the exposure of the mutant
to adenine is unlikely to be able to reduce PRPP level enough to cut off AIR
synthesis. An additional argument against the PRPP "shunt" mechanism is that
PRPP is required for tryptophan synthesis and tryptophan for protein synthesis.
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Protein synthetic rate for the S1237 mutant is about as high as for the wild type,
so PRPP is presumably in sufficient supply to allow tryptophan synthesis.
The transient responses of the purine nucleotides during a shift experiment are
much more complicated than would be expected if their kinetic behavior were
governed only by mass law. That AMP, GMP, and IMP drop after the shift is
expected since these derive directly from the externally supplied adenine.8 ADP
and GDP do not drop, however, and ATP (also GTP in the one experiment in
which it was measured) increases after the shift. In Fig. 5 the C and D IP* curves
show that the rate of nucleic acid synthesis does not increase as ATP level in-
creases after the shift but rather it starts to decrease. The rate of nucleic acid syn-
thesis then does not depend on the purine nucleotide triphosphate concentration
through mass law kinetics. It seems necessary to assume that regulatory mechanisms
exist which adjust the rate of nucleic acid synthesis to the rate of purine synthesis
independently of the levels of purine nucleotide diphosphates and triphosphates.
The utility of this kind of regulation is evident. For example, AT? and ADP are
required for glycolysis and oxidative phosphorylation. If their levels should be
lowered due to shortage of the purine base, carbohydrate metabolism would be
impaired. By reducing nucleic acid synthetic rate as soon as the precursors of ADP
and ATP-presumably AMP and/or IMP-decrease, the cell would be able to
continue carbohydrate metabolism instead of shutting it down along with nucleic
acid synthesis.
The transient behavior of the IMP also implies more than mass law control. The
drop in the intracellular level of IMP when the adenine level is lowered is pre-
dictable from mass law but the increase in level after a lag of 30 minutes to a new
steady-state level suggests that derepression of an enzyme required for the for-
mation of IMP has occurred during the 30 minutes. The increase in enzyme level
would permit increase in IMP level thus permitting feedback inhibition of attempted
de novo purine synthesis. Although repression control of nucleotide pyrophos-
phorylase has not to my knowledge been reported, repression of two of the enzymes
of IMP metabolism in bacterial mutants has been described by Levin and Magasanik
(10). In these mutants the formation of both inosinicase and IMP-dehydrogenase
is controlled by guanine derivatives.
With the identification of the controlling element of the feedback loop, IMP,
and the kinetic data presented here, a mathematical model of the purine nucleo-
tide system becomes possible. The complicated regulation of the nucleotide levels,
however, introduces difficulties which, though not insurmountable, require further
data on the characteristics of the nucleotide system.
This work was supported in part by United States Public Health Service grant AM 03727.
8The levels of free nucleotides are probably not influenced by turnover of nucleic acid since
in growing Saccharomyces cerevisiae the maximal breakdown rate is 0.01 per hour (7).
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